RadNet, Inc., a leading provider of high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, announced the successful closure of its underwritten public offering of 8,711,250 shares of common stock at a price of $29.75 per share, which includes the overallotment option to the underwriters of 1,136,250 shares. The gross proceeds to RadNet from the offering, before deducting underwriting discounts, commissions, and other expenses, are estimated to be approximately $259.2 million.
RadNet plans to utilise the net proceeds from the offering to repay $100 million of its primary lien term loans and for working capital and general corporate purposes.
Jefferies and Raymond James served as joint active book-running managers for the offering. Barclays, Truist Securities, RBC Capital Markets, and TD Securities also acted as joint book-running managers. CJS Securities acted as a co-manager.
The securities mentioned above were offered by RadNet in accordance with a previously filed and approved shelf registration statement by the Securities and Exchange Commission (SEC). Copies of the final prospectus supplement and accompanying prospectus related to the offering can be obtained from: Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, by phone at (877) 821-7388 or by email at [email protected]; or from Raymond James & Associates, Inc., Attention: Equity Syndicate, 880 Carillon Parkway, St. Petersburg, Florida 33716, by phone at (800) 248-8863 or by email at [email protected]. Electronic copies of the final prospectus supplement and accompanying prospectus were filed with the SEC and are available on the SEC's website at http://www.sec.gov.
Source: RadNet
